Research ArticleClinical Investigation
Short- and Long-Term Effects of 186Re-1,1-Hydroxyethylidene Diphosphonate in the Treatment of Painful Bone Metastases
Rosa Sciuto, Anna Tofani, Anna Festa, Diana Giannarelli, Rosella Pasqualoni and Carlo L. Maini
Journal of Nuclear Medicine April 2000, 41 (4) 647-654;
Rosa Sciuto
Anna Tofani
Anna Festa
Diana Giannarelli
Rosella Pasqualoni


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Short- and Long-Term Effects of 186Re-1,1-Hydroxyethylidene Diphosphonate in the Treatment of Painful Bone Metastases
Rosa Sciuto, Anna Tofani, Anna Festa, Diana Giannarelli, Rosella Pasqualoni, Carlo L. Maini
Journal of Nuclear Medicine Apr 2000, 41 (4) 647-654;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The Metastatic Spine Disease Multidisciplinary Working Group Algorithms
- Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
- Dosimetry of 188Re-Hydroxyethylidene Diphosphonate in Human Prostate Cancer Skeletal Metastases
- Bone Uptake Studies in Rabbits Before and After High-Dose Treatment with 153Sm-EDTMP or 186Re-HEDP
- The Placorhen Study: A Double-Blind, Placebo-Controlled, Randomized Radionuclide Study with 186Re-Etidronate in Hormone-Resistant Prostate Cancer Patients with Painful Bone Metastases
- Effects of Low-Dose Cisplatin on 89Sr Therapy for Painful Bone Metastases from Prostate Cancer: A Randomized Clinical Trial